Inspire Medical Systems (NYSE:INSP) Shares Gap Up to $221.63

Inspire Medical Systems, Inc. (NYSE:INSP)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $221.63, but opened at $227.99. Inspire Medical Systems shares last traded at $244.54, with a volume of 1,396,816 shares trading hands.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Royal Bank of Canada assumed coverage on shares of Inspire Medical Systems in a research note on Friday. They issued an “outperform” rating and a $285.00 price objective for the company. Mizuho reaffirmed a “buy” rating and set a $250.00 price target on shares of Inspire Medical Systems in a research note on Wednesday, March 27th. KeyCorp assumed coverage on shares of Inspire Medical Systems in a research note on Tuesday, February 6th. They set an “overweight” rating and a $278.00 price target for the company. Jefferies Financial Group assumed coverage on shares of Inspire Medical Systems in a research note on Friday, January 19th. They set a “buy” rating and a $245.00 price target for the company. Finally, Stifel Nicolaus reissued a “hold” rating and set a $210.00 target price on shares of Inspire Medical Systems in a research note on Tuesday, January 2nd. Four research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $272.20.

Inspire Medical Systems Price Performance

The firm has a market capitalization of $6.95 billion, a PE ratio of -325.84 and a beta of 1.37. The firm’s fifty day moving average is $202.84 and its two-hundred day moving average is $183.76.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings results on Tuesday, February 6th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.53. Inspire Medical Systems had a negative net margin of 3.39% and a negative return on equity of 3.93%. The business had revenue of $192.51 million for the quarter, compared to analysts’ expectations of $186.75 million. During the same period in the previous year, the company earned $0.10 earnings per share. The firm’s revenue for the quarter was up 39.6% compared to the same quarter last year. As a group, equities research analysts predict that Inspire Medical Systems, Inc. will post -0.35 EPS for the current fiscal year.

Insider Buying and Selling at Inspire Medical Systems

In other Inspire Medical Systems news, CFO Richard Buchholz sold 15,000 shares of the business’s stock in a transaction dated Wednesday, April 17th. The shares were sold at an average price of $230.03, for a total value of $3,450,450.00. Following the transaction, the chief financial officer now directly owns 28,271 shares in the company, valued at $6,503,178.13. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, insider Randy Ban sold 12,230 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $185.37, for a total value of $2,267,075.10. Following the completion of the sale, the insider now owns 3,029 shares of the company’s stock, valued at approximately $561,485.73. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Richard Buchholz sold 15,000 shares of the company’s stock in a transaction on Wednesday, April 17th. The shares were sold at an average price of $230.03, for a total transaction of $3,450,450.00. Following the completion of the sale, the chief financial officer now directly owns 28,271 shares of the company’s stock, valued at approximately $6,503,178.13. The disclosure for this sale can be found here. Insiders have sold a total of 76,371 shares of company stock worth $15,664,278 over the last three months. 4.10% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Inspire Medical Systems

Institutional investors have recently made changes to their positions in the business. Altshuler Shaham Ltd purchased a new stake in shares of Inspire Medical Systems in the 4th quarter valued at $29,000. McGlone Suttner Wealth Management Inc. purchased a new stake in Inspire Medical Systems during the 4th quarter valued at $27,000. Parkside Financial Bank & Trust purchased a new stake in Inspire Medical Systems during the 1st quarter valued at $37,000. Meeder Asset Management Inc. boosted its position in Inspire Medical Systems by 7,850.0% during the 4th quarter. Meeder Asset Management Inc. now owns 159 shares of the company’s stock valued at $40,000 after buying an additional 157 shares during the period. Finally, NBC Securities Inc. purchased a new stake in Inspire Medical Systems during the 3rd quarter valued at $34,000. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.